Researchers said today that a new drug dramatically slows the progression of Parkinson 's disease and should be used in all patients with early stages of the debilitating nerve illness . Based on preliminary results of a large-scale study , the researchers said the drug deprenyl delays the onset of advanced symptoms of Parkinson 's by at least one year and is remarkably safe . Parkinson 's is a degenerative disease of the nervous system that mostly strikes people over 40 . About 500,000 Americans suffer from it . `` I strongly recommend that all patients with early Parkinson 's be considered for this therapy , '' said Ira Shulson , a neurologist at the University of Rochester in Rochester , N.Y. , and the study 's principal investigator .